RBRK · Rubrik, Inc. — research history
Complete research history. Every dossier, draft, kill, publish, and lesson the system has produced on RBRK. Public so users can audit, AI can re-reference. Live price refreshes every 60s.
About RBRK · Rubrik, Inc.
Rubrik, Inc. provides data security solutions to individuals and businesses worldwide. The company offers enterprise data protection, unstructured data protection, cloud data protection, SaaS data protection solutions, and identity provider services protection; data threat analytics; data security posture; identity recovery and resilience services; and cyber recovery solutions. It also provides RUBY, an AI agent for cyber resilience designed to scale data security operations through automation; SENTRYAI, a proprietary AI deep learning-based platform for system health monitoring; and RUBRIK UNIVERSITY, which includes instructor-led training with hands-on labs, on-demand e-learning courses, and certification exams, as well as offers cloud services. It serves financial, retail, trade, transportation, energy, industrial, healthcare and life science, education, technology, media, communications, services, and public sectors. Rubrik, Inc. has strategic collaboration with MEDITECH to offer native cyber resilience to MEDITECH self-hosted cloud and on-premises solutions. Rubrik, Inc. was formerly known as Scaledata, Inc. and changed its name to Rubrik, Inc. in October 2014. The company was incorporated in 2013 and is based in Palo Alto, California.
Live Quote
HOLD (score +0) · 12-1 mom -28.1% · RSI 60 · above_both · -24.6% from high
Targets blend Wall Street consensus (28 analysts: low $85.00 / mean $95.50 / high $126.00) with chart-derived floors and ceilings.
1-Year Chart · RSI · MACD
Research Timeline
Newest first. Each entry shows what stage produced it, the verdict/decision, and the reasoning.
High valuation (113x forward P/E) and material insider selling ($16.5M) combined with active anti-signals (dilution, concentration) indicate no asymmetric edge or safe income structure at current levels.
High valuation (113x forward P/E) and material insider selling ($16.5M) combined with active anti-signals (dilution, concentration) indicate no asymmetric edge or safe income structure at current levels.
Rubrik reported an exceptional Q1 FY2027 beat (EPS +614%, 41% subscription revenue growth) that drove a sharp price recovery from its April lows ($43.81). The Form 4 cluster in the past 14 days is almost entirely RSU grants to directors at $0 strike, not open-market purchases — the true insider signal from CTO Arvind Nithrakashyap shows significant selling via pre-planned 10b5-1 plans (~16M USD over three trading days). No genuine CEO/CFO/board-level open-market purchase was found. The stock is still ~28% below its 52-week high but trades at a frothy forward P/E of ~113x with IV in the mid-60s. A bull case requires either (a) continued beats sustaining re-rating or (b) multiple expansion on AI-security tailwinds — neither of which constitutes an undiscovered edge.
RBRK triggered via Form 4 cluster (4 filings in 14 days), but after reading each filing in full, the insider activity is uniformly pre-scheduled 10b5-1 sales and routine RSU vesting/exercises — not opportunistic open-market purchases. The CTO sold ~$17M via a 10b5-1 plan over June 1-3 (2026), converting Class B shares while simultaneously selling Class A, but these are scheduled dispositions with no discretionary buy signal from any insider. The company is fundamentally strong: revenue +46% YoY, four consecutive EPS beats including the most recent fiscal Q4 FY26 where Rubrik turned profitable on both EPS and EBITDA for the first time. However, at a forward P/E of 136x with negative EBITDA margins (-24%), this stock is fully valued or rich relative to nearly any reasonable software-infrastructure comp. The near-term catalyst is tonight's (June 4) Q1 FY27 earnings report after market close; analyst consensus is a small EPS loss but the stock has run +50% in the past 30 days into the print, creating an elevated risk of a post-earnings sell-off especially given high IV (~90%). There are no open-market insider buys to support a bullish thesis and nothing material the market appears to be missing.